Connor, Clark & Lunn Investment Management (CC&L)’s Aravive, Inc. Common Stock ARAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-48,964
Closed -$570K 1167
2020
Q2
$570K Buy
48,964
+9,514
+24% +$113K ﹤0.01% 727
2020
Q1
$227K Buy
+39,450
New +$353K ﹤0.01% 849
2017
Q3
Sell
-4,998
Closed -$523K 937
2017
Q2
$523K Buy
4,998
+1,281
+34% +$138K ﹤0.01% 594
2017
Q1
$476K Buy
+3,717
New +$392K ﹤0.01% 634

Other funds holding ARAV

Connor, Clark & Lunn Investment Management (CC&L)'s ARAV Position: Q3 2020 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Aravive, Inc. Common Stock (ARAV) in Q3 2020, closing a stake of 48,964 shares — an estimated $570K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ARAV in Q1 2017 and held it in 4 quarters. The position peaked at $570K in Q2 2020. 51 funds tracked by Wall St. Rank hold ARAV as of Q3 2020.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Aravive, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 48,964 Aravive, Inc. Common Stock shares in Q3 2020, an estimated $570K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Aravive, Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Aravive, Inc. Common Stock position peaked at $570K in Q2 2020.
  • 51 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q3 2020.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2020, filed 12 Nov 2020.